PREPARE

PREPARE is a major clinical trial in the life insurance testing industry using PREVU* LT Skin Sterol Test, the lab-processed format of PreMD’s non-invasive cardiovascular risk assessment technology.

The clinical trial will include approximately 25,000 participants in the United States and will be conducted with the participation of certain U.S. life insurers, including Allstate Life Insurance Company. PREVU* LT will be performed on applicants for life insurance coverage who agree to participate in the study and compared with traditional risk assessment measures, including high sensitivity c-reactive protein (CRP). Test results will be collected and analyzed by LabOne, Inc.

Data from the study will determine the correlation between PREVU* LT and Framingham Global Risk Score, a traditional method for evaluating the risk of coronary artery disease. Studies with PREVU* LT to date show that skin cholesterol values as measured by PREVU* LT correlate to skin cholesterol values as measured by PREVU* POC.